Author

Theo Rispens 1

1 Sanquin Laboratories,Amsterdam,Netherlands

COMPARISON OF COMMERCIALLY AVAILABLE ASSAYS FOR INFLIXIMAB CONCENTRATIONS AND ANTIBODIES TO INFLIXIMAB WITH ASSAYS DEVELOPED AT JANSSEN AND USED IN CLINICAL STUDIES OF REMICADE® (INFLIXIMAB) IN IBD PATIENTS

Joseph Marini, Jocelyn Sendecki, Freddy Cornillie, Jay Popp, Marion Blank, Shawn Black, Kelly Y. Chun, Ann Gils, Thomas Van Stappen, Lina Therien, Dörte Hamann, Theo Rispens, Gopi Shankar

UNDETECTABLE FAECAL ANTI-TNF CONCENTRATIONS AFTER SUBCUTANEOUS ADMINISTRATION IN PATIENTS WITH MODERATE TO SEVERE ULCERATIVE COLITIS

Anne Strik, Sophie Berends, Theo Rispens, Annick de Vries, Mark Lowenberg, Krisztina Barbara Gecse, Ron Mathôt, Geert R. D'Haens

Item 1 - 2 / 2
1